New HDIT/HCT Treatment Offers Relief to MS Patients

A new experimental medical treatment is providing relief for relapsing-remitting multiple sclerosis patients. The treatment is accomplishing by giving patients a high dose of immunosuppressive therapy followed by transplantation of one’s stem cells. The treatment has induced sustained remission for MS patients. MS is a devastating disease where the immune system assaults the central nervous system. The treatment works by removing malfunctioning cells and using stem cells to reset the immune system.

Five years after getting HDIT/HCT 69 percent of patients who participated in the trial have lived without new MS symptoms. MS drugs that are currently available had lower success rates. The trial was funded by the National Institute of Allergy and Infectious Disease (NIAID). NIAID is part of the National Institutes of Health network. Researchers from the Immune Tolerance Network, which is under NIAID, conducted the medical trial. Both the three year and five year results were posted online on the journal of the American Academy of Neurology.

Various neurologists such as Dr. Shiva Gopal Vasishta welcomed these results as the treatment seems to be more effective than existing treatments. Additionally, some participants in the trail improved showing recovery in physical abilities and mobility. Dr. Anthony S. Fauci the director of NIAID stated that this one time treatment could be better that the available options.

The trial used 24 volunteer patients who were aged between 26 and 52 years. The patients had already taken clinically available treatments but had relapsed. There were some expected side effects such as infections but overall a majority of patients were better off. Only three participants died and their deaths were not related to the HDIT/HCT treatment.

Dr. Vasishta is a practicing Neurologist at the Eastern Neurodiagnostic Associates. He works primarily in the Voorhees area in New Jersey. He got his medical degree in 1979 and has 38 years’ experience in Neurology. He also has a specialty in psychiatry treatment. He accepts various insurance plans from Horizon Blue Cross Blue Shield, Medicare and Aetna. His practice supports English and Spanish.